Atlas Trials

Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients

Clinical trial NCT01318096 · UNKNOWN

Trial details

NCT number
NCT01318096
Sponsor
Yunnan AIDS Care Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
HBV CoinfectionHIV Infections
Start date
2011-03-01
Primary completion
2012-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.